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Pseudomonas aeruginosa is a challenging pathogen due to both innate and acquired
resistance to antibiotics. It is capable of causing a variety of infections, including
chronic lung infection in cystic fibrosis (CF) patients. Given the importance of iron
in bacterial physiology and pathogenicity, iron-uptake and metabolism have become
attractive targets for the development of new antibacterial compounds. P. aeruginosa
can acquire iron from a variety of sources to fulfill its nutritional requirements both in
the environment and in the infected host. The adaptation of P. aeruginosa to heme iron
acquisition in the CF lung makes heme utilization pathways a promising target for the
development of new anti-Pseudomonas drugs. Gallium [Ga(III)] is an iron mimetic metal
which inhibits P. aeruginosa growth by interfering with iron-dependent metabolism. The
Ga(III) complex of the heme precursor protoporphyrin IX (GaPPIX) showed enhanced
antibacterial activity against several bacterial species, although no inhibitory effect has
been reported on P. aeruginosa. Here, we demonstrate that GaPPIX is indeed capable
of inhibiting the growth of clinical P. aeruginosa strains under iron-deplete conditions, as
those encountered by bacteria during infection, and that GaPPIX inhibition is reversed
by iron. Using P. aeruginosa PAO1 as model organism, we show that GaPPIX enters
cells through both the heme-uptake systems has and phu, primarily via the PhuR
receptor which plays a crucial role in P. aeruginosa adaptation to the CF lung. We also
demonstrate that intracellular GaPPIX inhibits the aerobic growth of P. aeruginosa by
targeting cytochromes, thus interfering with cellular respiration.
Keywords: aerobic respiration, antibacterial, cystic fibrosis, gallium, heme, infection, iron-uptake, terminal
oxidases
INTRODUCTION
Pseudomonas aeruginosa is a challenging bacterial pathogen due to both innate and acquired
resistance to several antibiotics (Moore and Flaws, 2011). This bacterium is capable of causing
a variety of infections, including chronic lung infection, which represents the main cause of
morbidity and mortality in patients suffering from cystic fibrosis (CF) (Murphy, 2006; Davies et al.,
2007). The success of P. aeruginosa as an opportunistic pathogen relies, at least in part, on its
metabolic versatility, including the ability to obtain energy from different sources under a variety
of environmental conditions (Williams et al., 2007; Arai, 2011). P. aeruginosa possesses a branched
respiratory chain terminated by oxygen or nitrogen oxides, to allow growth by aerobic respiration
or by denitrification under anaerobic conditions, respectively (reviewed in Arai, 2011). Moreover,
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P. aeruginosa is able to ferment arginine and pyruvate
anaerobically (Vander et al., 1984; Eschbach et al., 2004). Aerobic
respiration in P. aeruginosa relies on five terminal oxidases
(Matsushita et al., 1982, 1983; Fujiwara et al., 1992; Cunningham
and Williams, 1995; Cunningham et al., 1997; Stover et al.,
2000; Comolli and Donohue, 2002, 2004). Three of these
enzymes, the aa3 terminal oxidase (Cox), the cbb3-1 (Cco-1),
and the cbb3-2 (Cco-2) are cytochrome c-type oxidases, while
the other two, i.e., the cyanide-insensitive oxidase (Cio) and
the bo3 oxidase (Cyo), are quinol oxidases (Figure 1). All these
terminal oxidases contain heme, and are differentially expressed
depending on the growth conditions, likely as a consequence to
their different affinity for oxygen (Alvarez-Ortega and Harwood,
2007; Kawakami et al., 2010). Denitrification is ensured by a set of
enzymes which sequentially convert nitrate (NO−3 ) to molecular
nitrogen (N2). Among the denitrification enzymes, only nitrite
reductase (Nir) and nitric oxide reductase (Nor) contain heme as
a cofactor (Figure 1).
Like almost all pathogenic bacteria, P. aeruginosa has an
absolute need for iron to cause infections and to persist
within the host (Ratledge and Dover, 2000). Iron is required
as a cofactor of many key enzymes involved in respiration,
DNA synthesis and defense against reactive oxygen species
(Andrews et al., 2003). However, in the human host, iron is
poorly available to bacteria due to its incorporation into heme-
containing molecules (e.g., hemoglobin and myoglobin) and iron
carrier proteins (e.g., transferrin and lactoferrin) (Weinberg,
2009). This iron-withholding capacity represents the first line
FIGURE 1 | Branched respiratory chain of P. aeruginosa. Cio, Cyo, Cox, Cco-1, and Cco-2 represent the five terminal oxidases that reduce oxygen to
water under aerobic conditions. Cio and Cyo are quinol oxidases while Cox, Cco-1, and Cco-2 are cytochrome c oxidases. Nar, Nir, Nor, and Nos are nitrate
reductase, nitrite reductase, nitric oxide reductase, and nitrous oxide reductase, respectively. These enzymes transfer electron to nitrogen oxides under anaerobic
conditions. Nar receives electrons directly from the quinone pool while the other three receive electrons via the cytochrome c or from the small blue-copper protein
azurin. a, b, c, and d represent different types of low-spin heme while a3, b3, d1, and o3 indicate the high-spin ones (modified from Arai, 2011).
of the host defense against invading pathogens, a phenomenon
known as “nutritional immunity” (Skaar, 2010). To circumvent
iron-limitation, P. aeruginosa possesses several systems that
actively acquire this essential metal, such as (i) the production
of the siderophores pyoverdine (Pvd, Meyer and Abdallah, 1978;
Cox and Adams, 1985) and pyochelin (Pch, Cox et al., 1981;
Heinrichs et al., 1991); (ii) the ability to utilize a wide range
of siderophores synthesized by other organisms (Cornelis and
Matthijs, 2002; Cornelis et al., 2009); (iii) the ability to acquire
Fe(II) through the Feo system (Cartron et al., 2006). In addition,
P. aeruginosa can utilize heme-iron, by expressing two distinct
heme-uptake systems, namely phu and has (Ochsner et al., 2000).
The phu system allows the direct acquisition of heme from
hemoproteins, which bind to the outer membrane receptor PhuR
(Ochsner et al., 2000). In the has system a secreted hemophore
HasA withdraws heme from hemoproteins and delivers it to the
outer membrane receptor HasR (Létoffé et al., 1998). Given the
similarity with the well-known has system of Serratia marcescens
(Rossi et al., 2003; Létoffé et al., 2004), it is likely that the has
system of P. aeruginosa positively regulates its own expression,
via the sigma factor HasI and anti-sigma HasS, upon interaction
of heme-loaded HasA with the HasR receptor (Llamas et al.,
2014). The expression of both has and phu heme-uptake systems
is shut down in the presence of sufficient intracellular iron, due
to the negative regulation exerted by the ferric-uptake regulator
(Fur) protein (Ochsner et al., 2000).
It has been shown that P. aeruginosa aerobic respiration and
iron-uptake capabilities play pivotal roles during chronic lung
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infection in CF patients. In particular, three terminal oxidases
(Cco-1, Cco-2, and Cio) sustain bacterial growth in the CF lung, a
particular environment where P. aeruginosa iron-uptake abilities
are sought to evolve toward heme utilization (Alvarez-Ortega and
Harwood, 2007; Marvig et al., 2014; Nguyen et al., 2014).
The paucity of effective antibiotics to treat P. aeruginosa
infections have made bacterial respiration and/or iron
metabolism promising targets for the development of new
anti-Pseudomonas drugs (Ballouche et al., 2009; Foley and
Simeonov, 2012; Imperi et al., 2013). The possibility of using
iron mimetics as novel therapeutics to interfere with iron
metabolism has been exploited (Kaneko et al., 2007; Banin
et al., 2008; Minandri et al., 2014). Ga(NO3)3, the active
component of the FDA-approved formulation Ganite R©, has
successfully been repurposed as an antimicrobial drug (Bonchi
et al., 2014; Rangel-Vega et al., 2015). Interestingly, Ga(NO3)3
has been shown to be very active against P. aeruginosa, by
interfering with iron-dependent metabolic pathways (Kaneko
et al., 2007; Bonchi et al., 2015). The antibacterial proprieties
of Ga(III) reside in the fact that, different from Fe(III), Ga(III)
cannot be reduced under physiological conditions. However,
redox cycling is critical for many of iron-dependent biological
functions, including respiration (Breidenstein et al., 2011).
Moreover, the heme-mimetic GaPPIX [i.e., Ga(III) coupled
with the heme precursor protoporphyrin IX] has been shown
to possess a good antibacterial activity against several bacterial
species, including Staphylococcus aureus and Acinetobacter
baumannii (Stojiljkovic et al., 1999; Arivett et al., 2015;
Chang et al., 2016). GaPPIX is likely to exploit heme-uptake
routes to enter bacterial cells, where it could substitute for
heme in heme-containing enzymes, including cytochromes,
catalases, and peroxidases, resulting in the perturbation of
vital cellular functions (Stojiljkovic et al., 1999). Due to the
similarity between GaPPIX and heme, GaPPIX is predicted
to interfere with heme-dependent b-type cytochromes, thus
impairing their function and ultimately inhibiting bacterial
respiration.
In this work, the in vitro effect of GaPPIX on P. aeruginosa
was tested under iron-depleted conditions, as those encountered
during infection. The entrance routes of GaPPIX into
P. aeruginosa cells and possible targets of GaPPIX were
investigated. We demonstrate that the sensitivity of P. aeruginosa
to GaPPIX depends on both intracellular iron levels and the
expression of heme-uptake systems. Furthermore, we show
that GaPPIX enters P. aeruginosa cells mainly through the
heme-uptake receptor PhuR. Evidence is also provided that
intracellular GaPPIX inhibits the aerobic growth of P. aeruginosa
by targeting heme-dependent b-type cytochromes.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Strains and plasmids used in this work are listed in Table 1.
P. aeruginosa clinical isolates are listed in Table S1. P. aeruginosa
strains from frozen cultures were maintained on Luria Bertani
(LB) agar before being transferred to liquid culture media.
Bacteria were cultured in iron-free Casamino Acids medium
(DCAA, Visca et al., 1993) supplemented or not with 100 µM of
FeCl3 at 37
◦C, with vigorous shaking. When required, antibiotics
were added to the media at the following concentrations for
Escherichia coli, with the concentrations used for P. aeruginosa
shown in parentheses: Ampicillin 100 µg/ml; carbenicillin (300
µg/ml in LB and 200 µg/ml in DCAA); and tetracycline
12.5 µg/ml (100 µg/ml). DCAA agar plates were prepared
by the addition of 15 g/l bacteriological agar (Acumedia,
Neogen corporation). When GaPPIX was required, a 50 mM
of stock solution of GaPPIX (Frontier Scientific) was prepared
in dimethyl sulfoxide (DMSO) and stored at 4◦C in the dark.
When Ga(NO3)3 was required, a 100 mM of stock solution
of Ga(NO3)3 (Sigma-Aldrich), was prepared in double-distilled
water and stored at−20◦C.
Susceptibility Testing
The activity of GaPPIX, Ga(NO3)3 and Hemin (Hm) (Sigma-
Aldrich) on P. aeruginosa was tested in 96-well microtiter plates
(Falcon). Briefly, bacterial cells were grown over-night in DCAA
supplemented with 100 µM FeCl3 in order to obtain high cell
densities, then washed in saline and diluted to an OD600 of
0.01 in 200 µl of DCAA containing increasing concentrations
(0–100 µM) of GaPPIX, Ga(NO3)3 or Hm. Microtiter plates
were incubated for 24 h at 37◦C with gentle shaking (120
rpm). Growth (OD600) was measured in a Wallac 1420
Victor3 V multilabel plate reader (PerkinElmer). The minimum
inhibitory concentration (MIC) of gallium compounds was
visually determined as the lowest concentration that completely
inhibited P. aeruginosa growth. As a control experiment the same
procedure was performed, except that 100 µM FeCl3 was added
in the medium containing the highest concentration of gallium
compounds tested (100 µM).
The antibacterial activity of gallium compounds was also
assessed by disk diffusion assays. Briefly, cells from an over-night
culture in DCAA supplemented with 100µMFeCl3 were washed
and diluted in saline to OD600 = 0.1, then seeded on the surface
of DCAA agar plates supplemented or not with FeCl3. Sterile
6-mm blank disks (ThermoFisher-Oxoid) soaked with 10 µl of
a 15mM solution of either GaPPIX or Ga(NO3)3 were deposited
on the agar surface and the Zone Of growth Inhibition (ZOI) was
measured (in mm) after 16 h of incubation at 37◦C.
To observe the rescue effect of Hm and Hemoglobin (Hb),
disks were soaked with 10 µl of a 7.5 mg/ml solution of bovine
hemin chloride (Sigma-Aldrich) in 10 mM NaOH or bovine
hemoglobin (Sigma-Aldrich) in phosphate buffered saline (PBS)
and deposited on the plate surface nearby the disk soaked with
GaPPIX. The appearance of a half-moon-shaped growth area
around the disk soaked with Hm or Hb was detected after 16 h
of incubation at 37◦C.
Construction of Plasmids for the
Expression of Heme Receptors
Plasmid preparations and DNA cloning were performed
according to standards methods (Sambrook et al., 1989).
Restriction and DNA modifying enzymes were used following
the instructions of the manufacturers. Oligonucleotide primers
are listed in Table 1. To express hasR in the 1hasR1phuR
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TABLE 1 | Bacterial strains and plasmids used in this study.
Strain or plasmid Genotype and/or relevant characteristics Reference or source
STRAINS
P. aeruginosa
PAO1 ATCC15692 (wild type, prototroph) American type culture collection
1hasR PAO11hasR This work
1phuR PAO11phuR This work
1hasR1phuR PAO11hasR1phuR Minandri et al., 2016
1pvdA PAO11pvdA Imperi et al., 2008
1pchD PAO11pchD Frangipani et al., 2014
1pvdA1pchD PAO11pvdA1pchD Visca et al., 2013
1cio PAO1 containing a 2400-bp deletion in the cioAB locus This work
1cox PAO1 containing a 4109-bp deletion in the coxBA-PA0107-coIII locus This work
1cyo PAO1 containing a 4830-bp deletion in the cyoABCDE operon This work
1cco PAO1 containing a 6445-bp deletion in the two adjacent ccoNOQP1 and ccoNOQP2 operons This work
1cyo1cio PAO1 mutated in both cyo and cio This work
1cyo1cco PAO1 mutated in both cyo and cco-1,2 This work
1cyo1cio1cox PAO1 mutated in cyo, cio and cox This work
1cyo1cco1cox PAO1 mutated in cyo, cco and cox This work
E. coli
DH5αF′ recA1 endA1 hsdR17 supE44 thi-1 gyrA96 relA1 1(lacZYA-argF ) U169 [880dlacZ1M15] NalR Sambrook et al., 1989
S17-1 λpir recA, thi, pro, hsdR-M+RP4: 2-Tc:Mu: Km Tn7 λpir, TpR SmR Simon et al., 1983
PLASMIDS
pDM4 Suicide vector; sacBR, oriR6K, CmR Milton et al., 1996
pME7541 Suicide construct used for deletion of the cioAB operon; TcR Frangipani et al., 2008
pME9302 Suicide construct used for deletion of the coxB-coIII cluster; TcR Frangipani et al., 2008
pME9303 Suicide construct used for deletion of the cyoABCDE operon; TcR Frangipani et al., 2008
pME9308 Suicide construct used for deletion of the two adjacent ccoNOQP operons; TcR Frangipani et al., 2008
pUCP18 E. coli-Pseudomonas shuttle vector derived from pUC18; ColE1, pRO1600, ApR, CbR Schweizer, 1991
pUCPhasR pUCP18 derivative carrying the coding sequence of hasR with its own promoter This study
pUCPphuR pUCP18 derivative carrying the coding sequence of phuR with its own promoter This study
pUCPphuRhasR pUCP18 derivative carrying the coding sequence of phuR and hasR with their own promoters Minandri et al., 2016
pDM41hasR pDM4 derivative carrying the flanking regions of the hasR coding sequence Minandri et al., 2016
pDM41phuR pDM4 derivative carrying the flanking regions of the phuR coding sequence Minandri et al., 2016
Oligonucleotides Sequence 5′-3′ Restriction site
hasR compl FW CGGGGTACCGGCGGGAGTGACGCTGC KpnI
hasR compl RV GAAGATCTCCTTCACTGGGCAAAACGG BglII
phuR compl FW CCGGAATTCGAAAGGCTGGGAGTGCTG EcoRI
phuR compl RV CGGGGTACCACCTGTGGCATGGAAAGC KpnI
TcR, tetracycline resistant; ApR, ampicillin resistant; CmR, chloramphenicol resistant; CbR, carbenicillin resistant; restriction sites in the oligonucleotides are underlined.
mutant, a 2932 bp fragment containing the hasR gene with its
own promoter region was amplified by PCR from the PAO1
genome using primers hasR compl FW and hasR compl RV
(Table 1). The product was then digested with KpnI and BglII and
directionally cloned into the corresponding sites of the shuttle
vector pUCP18, giving plasmid pUCPhasR. To express phuR in
1hasR1phuR mutant, a 2575 bp fragment containing the phuR
gene with its own promoter region was amplified by PCR from
the PAO1 genome using primers phuR compl FW and phuR
compl RV (Table 1). The product was then digested with EcoRI
and KpnI and directionally cloned into the corresponding sites
of the shuttle vector pUCP18, giving plasmid pUCPphuR. To
express hasR and phuR in the 1hasR1phuR mutant strain, the
pUCPhasRphuR plasmid previously described (Minandri et al.,
2016) was used.
Generation of P. aeruginosa Mutants
For mutant construction, E. coli and P. aeruginosa strains were
grown in LB, with or without antibiotics, at 37 and 42◦C,
respectively, with vigorous aeration. Previously described suicide
plasmids (Table 1) were used according to procedures detailed
elsewhere (Milton et al., 1996; Frangipani et al., 2008).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4 January 2017 | Volume 7 | Article 12
Hijazi et al. Anti-Pseudomonas Activity of Gallium-Protoporphyrin
Measurement of Cytochrome c Oxidase
Activity in P. aeruginosa Intact Cells
Cytochrome c oxidase activity was assayed by using the artificial
electron donor N,N,N’,N’tetramethyl-p-phenylene diamine
(TMPD) (Fluka). Briefly, bacteria were grown over-night in
DCAA supplemented with 100 µM FeCl3, then washed in
saline and inoculated in DCAA to a final OD600 = 0.05. When
the mid-exponential growth phase was reached (≈6 h post
inoculum), cells were washed once in saline and adjusted to an
OD600 = 1 (corresponding to≈10
9 CFU/ml).
Then, 108 bacterial cells (100 µl) were suspended in 1.4 ml of
33 mM potassium phosphate buffer (KPi, pH 7.0). The reaction
was started by the addition of 5 µl of a 0.54 M TMPD solution
to the sample cuvette. The rate of TMPD oxidation was recorded
spectrophotometrically at 520 nm for 8 min at 25◦C. Results were
expressed as µmol TMPD oxidized/min−1/108cells using 6.1 as
the millimolar extinction coefficient of TMPD (Matsushita et al.,
1982).
Isolation of Outer Membrane Proteins
(OMPs) and SDS-PAGE Analysis
OMPs were isolated following the sarcosyl solubilization method
(Filip et al., 1973), with some modifications. Briefly, bacteria
from over-night cultures in DCAA supplemented with 100 µM
FeCl3 and 200 µg/ml Cb were washed in saline, then diluted to
OD600 = 0.05 in 60 ml DCAA supplemented with 200 µg/ml
Cb, and incubated over-night at 37◦C. Cells were collected by
centrifugation (2500 × g, 20 min), washed with 5 ml of 30
mM Tris HCl (pH 8, Sigma-Aldrich) and suspended in 1 ml
of the same buffer. Bacteria were lysed by sonication in an
ice bath (8 × 20 s cycles in a Sonics Vibra-CellTM VCX 130
sonicator), punctuated by 20 s intervals (50% power). Phenyl
methyl sulfonyl fluoride (PMSF, Sigma-Aldrich) was added to cell
lysate at 1 mM final concentration. Unbroken cells were removed
by centrifugation at 2400 × g for 20 min, and supernatants were
transferred to fresh tubes. Sarcosyl (N-laurylsarcosinate sodium
salt, Sigma) was added to the supernatant to a final concentration
of 2%. After 1 h incubation at room temperature with gentle
shaking, the mixture was centrifuged for 2 h at 55,000× g at 4◦C.
OMP pellets were suspended in 40 µl 2 x SDS-PAGE loading dye
(Sambrook et al., 1989), boiled for 10 min, then separated by 8%
SDS-PAGE and visualized by Coomassie brilliant blue staining.
Statistical Analysis
Statistical analysis was performed with the software GraphPad
Instat (GraphPad Software, Inc., La Jolla, CA), using One-
Way Analysis of Variance (ANOVA), followed by Tukey-Kramer
Multiple Comparisons Test.
RESULTS
P. aeruginosa is Inhibited by GaPPIX under
Iron-Deplete Conditions
It has been previously reported that GaPPIX has no effect on
P. aeruginosa (Stojiljkovic et al., 1999). This results is quite
surprising given that P. aeruginosa is able to utilize heme as
an iron source, by expressing two heme-uptake systems, i.e.,
has and phu (Ochsner et al., 2000). However, since the effect
of GaPPIX has previously been investigated in iron-rich media
(Stojiljkovic et al., 1999), we sought that under these conditions
iron availability would have impaired Ga(III) activity. To verify
this hypothesis, we preliminary tested the effect of GaPPIX
on P. aeruginosa PAO1 growth using the iron-poor medium
DCAA (Visca et al., 1993), supplemented with increasing
concentrations of GaPPIX, the iron-binding porphyrin Hemin,
or Ga(NO3)3, the latter resulting very active on P. aeruginosa
in this medium (Bonchi et al., 2015). Ga(NO3)3 completely
inhibited P. aeruginosa growth at 12.5 µM, and its activity
was abrogated by the addition of FeCl3 (Figure 2A) consistent
with previous findings (Kaneko et al., 2007; Frangipani et al.,
2014). Although the minimal inhibitory concentration (MIC)
could not be determined for up to 100 µMGaPPIX (Figure 2A),
exposure of PAO1 to GaPPIX reduced bacterial growth by 50%
(IC50) at 12.5 µM (Figure 2A). Also in the case of GaPPIX,
growth inhibition was completely reversed by the addition of
FeCl3 (Figure 2A). As expected, exposure P. aeruginosa PAO1
to Hemin promoted bacterial growth at concentrations ranging
between 1.55 and 25 µM, in line with the ability of P. aeruginosa
to use Hemin as an iron source (Ochsner et al., 2000).
The GaPPIX susceptibility of P. aeruginosa PAO1 was also
tested using the disk diffusion assays in DCAA agar plates
supplemented or not with an excess of FeCl3 (600 µM)
(Figure 2B). In FeCl3-supplemented DCAA, both GaPPIX and
Ga(NO3)3 caused no inhibition of PAO1 growth. Conversely,
in DCAA a clear ZOI was observed around the GaPPIX and
Ga(NO3)3 disks (Figure 2B). Different from the ZOI formed
by Ga(NO3)3, the ZOI formed by GaPPIX was less transparent
(Figure 2B), consistent with the evidence that no MIC (full
inhibition) could be determined for GaPPIX in liquid DCAA
(Figure 2A). Although more transparent, the ZOI caused by
Ga(NO3)3 was smaller than that of GaPPIX (Figure 2B). These
preliminary data indicate that iron-deplete conditions render
P. aeruginosa PAO1 susceptible to GaPPIX-mediated growth
inhibition.
The Response of P. aeruginosa Cells to
GaPPIX Depends on Intracellular Iron
Carryover
The above results prompted us to investigate the effect of
the intracellular iron content on GaPPIX-dependent growth
inhibition. To this aim, the effect of GaPPIX was compared
between P. aeruginosa PAO1 cells that had been pre-cultured
in either DCAA containing 100 µM FeCl3 (to increase the
intracellular iron content) or DCAA without FeCl3 (to lower
the intracellular iron content). Iron-starved bacterial cells were
significantly more susceptible to GaPPIX (P< 0.001) compared
with those pre-cultured with FeCl3 (Figure 3A). In particular,
upon the addition of 0.38 µM GaPPIX, the growth of iron-
starved PAO1 cells was reduced by 40% compared with cells
pre-cultured in the presence of 100 µM FeCl3 (Figure 3A).
To further investigate the correlation between the intracellular
iron content and GaPPIX-dependent growth inhibition, GaPPIX
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FIGURE 2 | GaPPIX inhibits P. aeruginosa PAO1 growth under iron-deplete conditions. (A) P. aeruginosa PAO1 was grown for 24 h at 37◦C in DCAA in the
presence of different concentrations of Hemin (black bars), Ga(NO3)3 (dark gray bars), GaPPIX (light gray bars), or nothing (white bar). Control cultures were
supplemented with 100 µM FeCl3 and 100 µM of either Ga(NO3)3 or GaPPIX. Values are the mean of 3 independent experiments, each one performed in duplicate ±
the standard deviation. (B) Approximately 5 × 106 P. aeruginosa PAO1 cells were seeded on the surface of DCAA agar plates, supplemented or not with 600 µM
FeCl3, as indicated on top. Then, disks soaked with 10 µl of a 15 mM solution of either GaPPIX or Ga(NO3)3 were deposited on the agar surface, as indicated on the
left. Plates were incubated for 16 h at 37◦C. Images are representative of three independent experiments yielding similar results.
susceptibility was evaluated on P. aeruginosa mutants impaired
in Fe(III)-siderophore uptake systems, i.e., mutants unable
to synthesize pyoverdine (1pvdA), pyochelin (1pchD), or
both siderophores (1pvdA1pchD) (Figure 3B). While GaPPIX-
dependent growth inhibition was similar in the wild type and
the 1pchD mutant, both 1pvdA and 1pvdA1pchD mutants
were extremely sensitive to GaPPIX (Figure 3B). In particular,
0.38 µM GaPPIX inhibited the growth of the 1pvdA and
1pvdA1pchD mutant strains by 75 and 78%, respectively,
compared with the untreated cultures, while it reduced the
growth of the wild-type strain and of the 1pchD mutant by
only 40 and 30%, respectively (Figure 3B). Altogether, these data
indicate that the response of P. aeruginosa PAO1 to GaPPIX also
depends on the carryover of intracellular iron.
GaPPIX is Preferentially Uptaken via the
P. aeruginosa PhuR Receptor
To investigate the hypothesis that GaPPIX may enter
P. aeruginosa cells by exploiting the same routes as heme,
P. aeruginosamutants carrying a deletion of either of the known
heme receptors (1hasR and 1phuR mutants; Table 1) were
generated. The effect of GaPPIX on these mutants, as well as
on a 1hasR1phuR double mutant lacking both heme receptors
(Minandri et al., 2016), was investigated in DCAA in the
presence of 12.5 µMGaPPIX (IC50; Figure 4A). While all strains
showed the same growth profiles in the untreated medium,
both 1phuR and 1hasR1phuR mutants grew better than the
wild type or the 1hasR mutant in the presence of 12.5 µM
GaPPIX, displaying ≈50% higher growth levels relative to the
wild type or the 1hasR mutant (Figure 4A). These data suggest
that, among the P. aeruginosa heme-uptake systems, phu has a
more prominent role than has in the uptake of GaPPIX. Then,
the effect of GaPPIX on heme-receptor mutants was evaluated
in DCAA agar plates, by performing the disk diffusion assays
(Figure 4B). Results showed a similar ZOI (27.6 ± 2.0 mm) for
both the wild-type strain and the 1hasR mutant, while a smaller
ZOI (24.5 ± 0.7 mm) was observed for the 1phuR mutant,
indicating a less susceptible phenotype (Figure 4B, Table S2).
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FIGURE 3 | The response of P. aeruginosa to GaPPIX depends on intracellular iron carryover. (A) P. aeruginosa PAO1 cells from an inoculum with 100 µM
FeCl3 (black bars) and without FeCl3 (white bars) were grown in DCAA supplemented with increasing concentrations of GaPPIX for 24 h at 37
◦C. The values are
expressed as the percentage relative to the untreated cultures, and represent the mean of four independent experiments, each one performed at least in duplicate ±
the standard deviation. Asterisks indicate statistically significant differences relative to a culture derived from cells grown in the presence of 100 µM FeCl3 (***P <
0.001). (B) P. aeruginosa PAO1 (white bars), 1pchD (light gray bars), 1pvdA (dark gray bars), and 1pvdA1pchD (black bars) were grown in DCAA supplemented with
increasing concentrations of GaPPIX for 24 h at 37◦C. Values are the mean of two independent experiments, each one performed in duplicate ± the standard
deviation.
In addition, no ZOI was observed for the 1hasR1phuR double
mutant, indicating a fully resistant phenotype (Figure 4B).
These observations indicate that both has and phu systems
are implicated in GaPPIX transport, although the phu system
appears to be the preferential route for the entrance of GaPPIX
in P. aeruginosa cells (Figure 4B).
The Sensitivity of P. aeruginosa to GaPPIX
Depends on the Expression of the
Heme-Uptake Receptors
To further investigate the contribution of the HasR and
PhuR receptors to GaPPIX-uptake, we individually expressed
multicopy hasR, phuR, or both hasR and phuR in the
1hasR1phuR mutant strain (using plasmids pUCPhasR,
pUCPphuR, or pUCPhasRphuR, respectively) (Figure 5A). The
effect of GaPPIX on these strains was initially tested by the
disk diffusion assays (Figure 5A). While, the empty pUCP18
vector did not alter the susceptibility of 1hasR1phuR to
GaPPIX (cfr Figures 5A, 4B), the expression of hasR from
the multicopy plasmid pUCPhasR made the 1hasR1phuR
mutant more susceptible to GaPPIX (ZOI = 27.6 ± 2.0 mm)
(Figure 5A, Table S2). The effect of GaPPIX was even more
pronounced in the 1has1phuR mutant overexpressing either
phuR (1has1phuR carrying the multicopy plasmid pUCPphuR;
ZOI = 34.0 ± 1.0 mm) or both hasR and phuR (1has1phuR
carrying the multicopy plasmid pUCPhasRphuR; ZOI = 33.3
± 0.5 mm) (Figure 5A, Table S2). GaPPIX sensitivity of the
1has1phuR strain expressing hasR, phuR, or both genes, was
also evaluated in DCAA liquid medium, in the presence of
different concentrations of GaPPIX (Figure 5B). All strains
grew equally in the untreated medium, and GaPPIX did not
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FIGURE 4 | GaPPIX enters P. aeruginosa cells through the heme-uptake systems. (A) Growth of P. aeruginosa wild type (diamond) and 1hasR (square),
1phuR (triangle), and 1hasR1phuR (circle) mutant strains in DCAA supplemented or not with 12.5 µM GaPPIX at 37◦C. Values are the mean of two independent
experiments, each one performed in duplicate ± the standard deviation. (B) Approximately 5 × 106 bacterial cells were seeded on DCAA agar plates, then disks
soaked with 10 µl of a 15 mM solution of GaPPIX were deposited on the agar surface. Plates were incubated for 16 h at 37◦C. Images are representative of three
independent experiments yielding similar results.
affect the growth of 1hasR1phuR/pUCP18 up to 25 µM
(Figure 5B). Conversely, strains 1hasR1phuR/pUCPhasR,
1hasR1phuR/pUCPphuR, and 1hasR1phuR/pUCPhasRphuR
were very sensitive to GaPPIX. In particular, 0.38 µM GaPPIX
reduced the growth of the 1hasR1phuR/pUCPhasR strain
by 56%, and by >80% in both 1hasR1phuR/pUCPphuR
and 1hasR1phuR/pUCPhasRphuR strains (Figure 5B). This
effect was much more pronounced than that observed for the
parental strain PAO1 (Figure 2A). Of note, no further growth
reduction was observed for both the 1hasR1phuR/pUCPphuR
and 1hasR1phuR/pUCPhasRphuR mutant strains at > 0.38
µM GaPPIX. The increased sensitivity of the 1hasR1phuR
strain expressing either hasR or phuR, relative to the wild type,
can be explained by the overexpression of heme receptors
from the multicopy plasmid pUCP18 (Figure 5A). To confirm
this hypothesis, HasR and PhuR protein levels were visualized
by SDS-PAGE analysis of OMPs purified from the different
P. aeruginosa strains cultured in DCAA (Figure 5C). By
comparing P. aeruginosa outer-membrane-proteins profiles of
the wild type, the1phuR or the1hasR1phuRmutant strains, the
lack of a ca. 75 kDa protein in the 1phuR or the 1hasR1phuR
mutants, was observed. This was in good agreement with a
predicted molecular mass of 82 kDa for the mature PhuR
receptor. Moreover, a protein band at that position was evident in
SDS-PAGE electropherograms of the 1hasR1phuR/pUCPphuR
and the 1hasR1phuR/pUCPhasRphuR complemented mutants
(Figure 5C). Similarly, a protein band corresponding to
ca. 94 kDa, consistent with the HasR receptor mass, was
absent in the 1hasR and 1hasR1phuR mutants, while
it was clearly detectable in the 1hasR1phuR/pUCPhasR
and 1hasR1phuR/pUCPhasRphuR complemented mutants
(Figure 5C). In line with previous results (Ochsner et al., 2000),
protein levels greatly differed between PhuR and HasR, the
latter being poorly expressed in wild-type PAO1. These results
confirm that both HasR and PhuR direct GaPPIX entrance in
P. aeruginosa cells, and argue for a prominent role of PhuR as
a consequence of its higher expression levels, compared with
HasR.
To confirm the specificity of GaPPIX for both heme-uptake
systems, we investigated whether the growth inhibitory effect of
GaPPIX could be rescued by the presence of Hemin (Hm) or
Hemoglobin (Hb), which are known to deliver iron via heme-
uptake receptors (Ochsner et al., 2000). To this aim, the heme-
uptake mutant 1hasR1phuR overexpressing either PhuR or
HasR was tested in the GaPPIX disk diffusion assays in the
presence of Hm and Hb (Figure 5D). Both Hm and Hb partly
rescued the growth of the 1hasR1phuR mutant overexpressing
either PhuR (from pUCPphuR) or HasR (from pUCPhasR) thus
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FIGURE 5 | The sensitivity of P. aeruginosa to GaPPIX depends on the expression of heme-uptake systems. (A) Approximately 5 × 106 bacterial cells were
seeded on DCAA agar plates containing 200 µg/ml Cb, then disks soaked with 10 µl of a 15 mM solution of GaPPIX were deposited on the agar surface. Plates were
incubated for 16 h at 37◦C. (B) Growth of the P. aeruginosa 1hasR1phuR mutant strain carrying the empty vector pUCP18 (white bars), or overexpressing hasR from
plasmid pUCPhasR (light gray bars) or phuR from plasmid pUCPphuR (dark gray bars), or both hasR and phuR from plasmid pUCPhasRphuR (black bars), in DCAA
supplemented with increasing concentrations of GaPPIX for 24 h at 37◦C. (C) SDS-PAGE analysis of the outer membrane proteins of different P. aeruginosa PAO1
strains. Strains and plasmids are indicated on the top of each lane. M is the molecular mass marker (kDa), with band sizes on the left. The position of the putative 82
kDa PhuR and 94 kDa HasR outer membrane receptors is indicated by arrows on the right. (D) Rescue effect of hemin (Hm) or hemoglobin (Hb) from GaPPIX growth
inhibition in the 1hasR1phuR mutant strain overexpressing either phu from plasmid pUCPphuR or hasR from plasmid pUCPhasR. Approximately 5×106 bacterial
cells were seeded on DCAA agar plates containing 200 µM Cb. Blank discs were soaked with 10 µl of a 15 mM solution of GaPPIX or with 75 µg of either Hm or Hb.
Plates were incubated at 37◦C for 16 h. (E) Growth of the P. aeruginosa 1pvdA1pchD mutant strain carrying the empty vector pUCP18 (black bars), or
overexpressing both hasR and phuR from plasmid pUCPhasRphuR (white bars), in DCAA supplemented with increasing concentrations of GaPPIX for 24 h at 37◦C.
Values are the mean of two independent experiments, each one performed in triplicate ± the standard deviation. Images in B and D are representative of two
independent experiments yielding similar results.
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confirming that (i) Hm, Hb and GaPPIX compete with heme
receptors and (ii) GaPPIX enters P. aeruginosa cells through
PhuR and HasR (Figure 5D).
It has been observed that P. aeruginosa isolates evolving
during chronic lung infection in CF patients tend to accumulate
mutations in siderophore loci, concomitant with preferential
utilization of heme iron (Cornelis and Dingemans, 2013; Marvig
et al., 2014; Andersen et al., 2015). To simulate this situation,
we tested GaPPIX susceptibility of a siderphore-defective
P. aeruginosa mutant overexpressing both PhuR and HasR
receptors (1pvdA1pchD/pUCPhasRphuR). Whereas, exposure
of the1pvdA1pchDmutant to GaPPIX reduced bacterial growth
by 82% at 0.38 µM, expression of both hasR and phuR from
multicopy plasmid pUCPhasRphuR made the 1pvdA1pchD
mutant extremely susceptible to GaPPIX, displaying 90% growth
reduction (IC90) at 0.38 µM (Figure 5E). Notably, full inhibition
of the 1pvdA1pchD/pUCPhasRphuR strain was observed upon
challenge with 50 µMGaPPIX.
GaPPIX Targets the Aerobic Respiration of
P. aeruginosa
GaPPIX has been proven effective against a wide range of
pathogenic bacteria by targeting metabolic pathways that require
heme as an enzymatic cofactor, such as cellular respiration
(Stojiljkovic et al., 1999). Thus, we investigated whether GaPPIX
could interfere with the activity of terminal oxidases implicated
in P. aeruginosa aerobic respiration. In particular, we focused
on Cco-1, Cco-2, and Cio, which have been shown to sustain
P. aeruginosa growth under low oxygen conditions, as those
encountered in the lung of CF patients (Alvarez-Ortega and
Harwood, 2007; Kawakami et al., 2010). To this aim, we
initially tested the sensitivity of cytochrome c oxidases (i.e., Cox,
Cco-1, and Cco-2) to GaPPIX. Strains deleted of the whole
operon encoding the terminal oxidase Cox (1cox) or both the
Cco-1 and Cco-2 terminal oxidases (1cco) were generated in
the same parental strain used to generate the heme-receptor
mutants (Table 1). The effect of GaPPIX was then assayed on
these cytochrome-defective mutants using the TMPD redox
indicator, which is an artificial electron donor to the cytochrome
c (Matsushita et al., 1982). Oxidation of TMPD to a blue
indophenol compound indicates electron flow to the cytochrome
c terminal oxidases. Thus, cytochrome c oxidase activity was
measured on P. aeruginosa PAO1 and in the 1cox and 1cco
mutants grown in DCAA supplemented or not with a sub-
inhibitory concentration of GaPPIX (4 µM). In whole cells
cultured in the untreated medium, no cytochrome c oxidase
activity could be measured in the 1cco strain (Figure 6A),
confirming that in our conditions the TMPD test mainly
measures the activity of Cco. Indeed, the 1cox mutation does
not affect the TMPD oxidase activity (Figure 6A), as previously
reported (Frangipani and Haas, 2009). This is because Cox is
known to be poorly expressed during P. aeruginosa exponential
growth (Kawakami et al., 2010). Interestingly, 4 µM GaPPIX
reduced the respiratory activity by more than 50% in the wild-
type strain PAO1 and the 1cox mutant, compared with the
untreated condition (Figure 6A). These observations suggest that
Cco-1 and Cco-2 terminal oxidases are sensitive to GaPPIX. To
confirm these preliminary results, the effect of GaPPIX was tested
on a mutant expressing only Cco-1 and Cco-2. To this aim, a
1cyo1cio1cox triple mutant strain was generated. Disk diffusion
assays showed that the1cyo1cio1coxmutant wasmore sensitive
to GaPPIX than the wild type (ZOI = 34.6 ± 1.24 vs 27.6 ±
2.0 mm, respectively) (Figure 6B, Table S2). Similar results were
obtained in DCAA liquid cultures. PAO1 wild type and the
1cyo1cio1cox mutant showed a similar growth profile in the
untreated medium (Figure 6C), whereas exposure to 0.38 µM
GaPPIX reduced bacterial growth by 40% and 68%, respectively,
relative to the untreated cultures (Figure 6C). Interestingly, it was
possible to determine an IC90 at 82 µM for the 1cyo1cio1cox
mutant strain (Figure 6C). These results confirm that Cco-1 and
Cco-2 are targeted by GaPPIX.
Then, the effect of GaPPIX on the Cio terminal oxidase
was assessed. To this purpose, sodium azide (NaN3) was used
as a specific inhibitor of copper-dependent oxidases, i.e., all
terminal oxidases except Cio (Cunningham andWilliams, 1995).
Preliminarily, we determined the minimal NaN3 concentration
inhibiting all terminal oxidases except Cio in DCAA, by
comparing the growth of wild-type PAO1 and the1ciomutant in
the presence of increasing NaN3 concentrations (250–1000 µM).
We observed that 350 µM of NaN3 completely inhibited the
1cio mutant without affecting PAO1 growth (data not shown).
Then, the sensitivity of Cio to GaPPIX was tested by performing
a GaPPIX disk diffusion assays with wild-type PAO1 in DCAA
supplemented or not with 350 µM NaN3. It was observed that
PAO1 remains sensitive to GaPPIX in the presence of 350 µM
NaN3, displaying a ZOI even greater than that obtained for
PAO1 without NaN3 (36.6 ± 3.0 vs 27.6 ± 2.0 mm, respectively)
(Figure 7A, Table S2). This result provides evidence that Cio is
a target for GaPPIX. To strengthen this evidence, a P. aeruginosa
1cyo1cco1cox triple mutant, which expresses only Cio (Table 1)
was constructed and assayed for GaPPIX susceptibility. Disk
diffusion assay results showed that the 1cyo1cco1cox mutant
was more sensitive to GaPPIX than the wild-type PAO1 (ZOI
= 30.0 ± 0.7 vs 27.6 ± 2.0 mm, respectively) (Figure 7A, Table
S2). Similar results were also obtained in DCAA liquid medium,
showing that GaPPIX significantly reduced (P < 0.001) the
growth of the1cyo1cco1cox mutant relative to the wild type, at
concentrations ranging between 0.38 and 6.25 µM (Figure 7B).
Altogether, the above results indicate that P. aeruginosa Cco-1,
Cco-2, and Cio terminal oxidases are targets for GaPPIX.
P. aeruginosa Clinical Isolates Are
Sensitive to GaPPIX
The expression of P. aeruginosa genes encoding heme-uptake
systems has recently been detected in sputum samples collected
from CF patients (Konings et al., 2013), and an evolution
toward preferential heme utilization has been documented in
P. aeruginosa during the course of chronic lung infection in
CF patients (Marvig et al., 2014; Nguyen et al., 2014). Given
the importance of heme in sustaining P. aeruginosa growth
during infection, we have comparatively assessed the response to
Ga(NO3)3 and GaPPIX in a collection of P. aeruginosa clinical
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 January 2017 | Volume 7 | Article 12
Hijazi et al. Anti-Pseudomonas Activity of Gallium-Protoporphyrin
FIGURE 6 | GaPPIX inhibits P. aeruginosa PAO1 growth by targeting Cco. (A) TMPD oxidase activity on whole cells of wild-type PAO1, 1cox and 1cco
mutants grown for 6 h in DCAA supplemented (black bars) or not (white bars) with 4 µM GaPPIX. Activity is expressed as µmol TMPD oxidized/min−1/108 cells at pH
7.0 and 25◦C. Each value is the average of three independent experiments, each one performed in triplicate ± the standard deviation. (B) Approximately 5 × 106
bacterial cells of wild-type PAO1 and the 1cyo1cio1cox triple mutant were seeded on DCAA agar plates, then disks soaked with 10 µl of a 15 mM solution of
GaPPIX were deposited on the agar surface. Plates were incubated for 16 h at 37◦C. Images are representative of two independent experiments giving similar results.
(C) Growth of wild type PAO1 (open circle) and the 1cyo1cio1cox triple mutant (open square) in DCAA supplemented with increasing GaPPIX concentrations, for 24
h at 37◦C. Values are representative of two independent experiments, each one performed in triplicate ± the standard deviation.
isolates from CF and non-CF patients (Figure 8, Table S1).
Although GaPPIX (up to 100 µM) never abolished P. aeruginosa
growth, the majority of clinical isolates (>70%) was sensitive to
GaPPIX, displaying an IC50 values in the range 0.1–15.2 µM
(Table S1). Moreover, all but one P. aeruginosa clinical isolates
were significantly more susceptible than the reference PAO1
strain (Figure 8). In line with previous reports (Bonchi et al.,
2015), all clinical isolates except one (FM1, Table S1) were very
sensitive to Ga(NO3)3, showing IC50 values ranging from 0.2 to
9 µM (Table S1).
DISCUSSION
The ability of pathogenic bacteria to colonize the host and
cause infections is dependent on their capability to acquire iron
and generate energy to sustain in vivo growth (Ratledge and
Dover, 2000; Alvarez-Ortega and Harwood, 2007; Hammer et al.,
2013). The success of P. aeruginosa as a pathogen relies on the
presence of several iron-uptake systems (reviewed in Llamas
et al., 2014), as well as on amultiplicity of terminal oxidases which
allow bacterial respiration in vivo. Both iron-uptake systems
and respiratory cytochromes have been shown to contribute
to P. aeruginosa fitness during chronic lung infection in CF
patients (Alvarez-Ortega and Harwood, 2007; Konings et al.,
2013). Recent observations have documented an adaptation of
P. aeruginosa toward heme iron acquisition in the CF lung, where
bacterial energy metabolism mainly relies on the three terminal
oxidases Cco-1, Cco-2, and Cio, all of which have high affinity for
oxygen (Alvarez-Ortega and Harwood, 2007). These data suggest
that heme utilization pathways and respiratory cytochromes
could represent candidate targets for the development of new
anti-Pseudomonas drugs (Alvarez-Ortega and Harwood, 2007;
Marvig et al., 2014; Nguyen et al., 2014). Indeed, targeting
bacterial membrane functions such as cellular respiration, are
considered promising therapeutic opportunities, especially in the
case of persistent or chronic infections (Hurdle et al., 2011).
Given that all terminal oxidases require heme as a cofactor, and
that heme-uptake systems are expressed during chronic lung
infection, in this work we have investigated the effect of the
heme-mimetic GaPPIX against P. aeruginosa. We focused on
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FIGURE 7 | GaPPIX inhibits P. aeruginosa PAO1 growth by targeting Cio. (A) Approximately 5 × 106 bacterial cells were seeded on DCAA agar plates, then
disks soaked with 10 µl of a 15 mM solution of GaPPIX were deposited on the surface of DCAA agar plates supplemented or not with 350 µM NaN3. Plates were
incubated for 16 h at 37◦C. Strains and conditions are indicated on top of each panel. Images are representative of two independent experiments giving similar
results. (B) Growth inhibition (%) of wild type PAO1 (white bars) and the 1cyo1cco1cox triple mutant (gray bars) in DCAA supplemented with increasing
concentrations of GaPPIX relative to the untreated controls (no GaPPIX). Growth was measured after 24 h incubation at 37◦C. Values are representative of four
independent experiments, each one performed at least in duplicate ± the standard deviation. Asterisks indicate statistically significant differences between the wild
type PAO1 and the 1cyo1cco1cox triple mutant (P < 0.001).
Cco-1, Cco-2, and Cio since P. aeruginosa uses any of these
three terminal oxidases to support the microaerobic growth
necessary to thrive in the lung of CF patients. Cox and Cyo
are not expressed or strongly repressed under these conditions
(Alvarez-Ortega and Harwood, 2007).
We have initially demonstrated that GaPPIX is able to reduce
the growth of P. aeruginosa only under iron-limiting growth
conditions. However, different from Ga(NO3)3, bacterial growth
was never completely inhibited at GaPPIX concentrations up
to 100 µM (Figure 2A), in line with the fact that the ZOI for
GaPPIX was less transparent compared with that generated by
Ga(NO3)3 in the disk diffusion assays (Figure 2B). This diverse
response of P. aeruginosa upon exposure to GaPPIX or Ga(NO3)3
(Figures 2A,B) could be explained by the fact that GaPPIX
and Ga(NO3)3 enter bacterial cells through different pathways.
Ga(NO3)3 may enter P. aeruginosa cells (i) by diffusion; (ii)
through the HitAB iron transport proteins (García-Contreras
et al., 2013); or (iii) via the siderophore Pch (Frangipani et al.,
2014). On the other hand, we have demonstrated that GaPPIX
can cross the P. aeruginosa outer membrane only through the
heme-receptors HasR and PhuR, since a 1hasR1phuR mutant
is fully resistant to GaPPIX (Figure 4). Indeed, overexpression of
heme receptors in the 1hasR1phuR mutant makes this strain
susceptible to GaPPIX, at even lower GaPPIX concentrations
compared with wild-type PAO1 (Figures 5A,B). However, it
should also be taken into consideration that GaPPIX and
Ga(NO3)3 likely have different targets. In fact, while Ga(NO3)3
is known to target a variety of essential iron-containing enzymes
(Bernstein, 1998; Soo et al., 2016), less is known about GaPPIX
targets. Several studies have demonstrated that the antibacterial
activity of GaPPIX relies on the molecule as a whole, since
GaPPIX cannot be cleaved by bacterial enzymes (Stojiljkovic
et al., 1999; Hammer et al., 2013). In fact, we demonstrated that
the homolog of GaPPIX (Hemin) did not affect P. aeruginosa
PAO1 growth. Indeed, Hemin promoted bacterial growth at
concentrations ranging between 1.55 and 25 µM (Figure 2A),
likely as a consequence of iron delivery to the cell, combined
with positive regulation of the has system (Llamas et al., 2014).
Hence, GaPPIX might be erroneously incorporated in heme-
containing proteins such as cytochromes. However, due to the
multiplicity of pathways involving cytochromes, exposure to
GaPPIX never results in a complete growth inhibition. This
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FIGURE 8 | Susceptibility of P. aeruginosa clinical isolates to GaPPIX.
IC50 values of GaPPIX or Ga(NO3)3 in a collection of P. aeruginosa clinical
isolates (black) and in the reference strains PAO1 (white). Bacteria were grown
for 24 h at 37◦C in DCAA with increasing concentrations of GaPPIX or
Ga(NO3)3 to determine the IC50. The IC50 of PAO1 was 12.5 µM for GaPPIX
and 5.2 µM for Ga(NO3)3.
hypothesis is supported by the observation that GaPPIX is
more active against P. aeruginosa mutants deleted in some of
the cytochrome-dependent terminal oxidases (Figures 6, 7). In
fact, a P. aeruginosa mutant that only expresses the terminal
oxidases Cco-1 and Cco-2 (1cyo1cio1cox) is much more
sensitive to GaPPIX than the wild-type strain. In addition, the
1cyo1cio1coxmutant showed a 68% growth reduction in liquid
DCAA at 0.38 µM GaPPIX, compared to the untreated cultures,
and an IC90 of 82 µM (Figures 6B,C). Along the same lines, a
P. aeruginosa strain that only relies on the terminal oxidase Cio
to respire oxygen, is more sensitive to GaPPIX than the wild-
type strain (Figure 7). Taken together, our results demonstrate
that GaPPIX targets P. aeruginosa respiratory cytochromes Cco-
1, Cco-2, and Cio, which are exclusively found in bacteria
(Cunningham and Williams, 1995; Pitcher and Watmough,
2004), although we cannot discriminate which of the Cco
cytochromes is preferentially targeted by GaPPIX (the 1cco-
1,2 strain is mutated in both). Moreover, it is tempting to
speculate that GaPPIX may also inhibit the other terminal
oxidases Cyo and Cox (Figure 1), as well as some of the enzymes
involved in denitrification, such as the heme-containing protein
complexes Nir and Nor (Figure 1). Moreover, GaPPIX could also
be incorporated into heme-containing enzymes involved in the
protection from oxidative stress, increasing the susceptibility of
P. aeruginosa to reactive oxygen species.
Although it was not possible to determine the MIC
of GaPPIX for wild-type PAO1, it is worth to point out
that GaPPIX was extremely active against a P. aeruginosa
mutant impaired in siderophore production (1pvdA1pchD)
and overexpressing both HasR and PhuR heme receptors from
plasmid pUCPhasRphuR (Figure 5). Ninety percent growth
reduction and full inhibition were observed upon exposure of
this mutant to 0.38 and 50.0 µM GaPPIX, respectively. It is
tempting to speculate that such strong inhibition could also
occur in the CF lung, where siderophore-defective P. aeruginosa
variants emerge during chronic infection, and heme represents
the principal iron source (Marvig et al., 2014; Nguyen et al., 2014).
Inhibition could further be enhanced under the microaerobic
conditions encountered by P. aeruginosa in the CF airways
(Hogardt and Heesemann, 2010), where the three high affinity
terminal oxidases targeted by GaPPIX (Cco-1, Cco-2, and
Cio) are essential for bacterial growth (Alvarez-Ortega and
Harwood, 2007). Irrespective of the Ga(III) delivery system and
of the energy metabolism adopted by P. aeruginosa, the balance
between Fe(III) and Ga(III) availability in vivo will be the main
determinant of Ga(III) efficacy. The inhibitory activity of GaPPIX
was not limited to the prototypic strain PAO1, as it was also
exerted on a representative collection of P. aeruginosa clinical
isolates (Table S1). The great majority of clinical isolates (>70%)
was sensitive to GaPPIX, irrespective of their origin, and all but
one were significantly more susceptible than PAO1 (IC50 ≤ 3.2
µM, Table S1).
Interestingly, studies on several human cell lines report that
GaPPIX does not show cytotoxicity at concentrations ≤ 128
µM (Stojiljkovic et al., 1999; Chang et al., 2016), far above the
concentrations that we found active on P. aeruginosa clinical
isolates. Moreover, GaPPIX did not show to affect the health
and behavior of mice, when administered by intraperitoneal
injections (25–30 mg/kg) followed by four daily doses of (10–12
mg/kg) (Stojiljkovic et al., 1999), though it reduced the survival
of Galleria mellonella larvae by 50% (LC50) when injected at 25
mM (Arivett et al., 2015).
Although further studies are needed to assess the effect of
GaPPIX against P. aeruginosa infection in vivo, our work should
encourage future research directed to the development of heme-
mimetic drugs targeting cellular respiration for the treatment of
P. aeruginosa chronic lung infection.
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